BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Genetics Squared Names New President/CEO, Bolsters Management For Product Developments


10/19/2005 5:11:06 PM

ANN ARBOR, Mich., April 29 /PRNewswire/ -- An experienced technology and biotech executive has been named president and chief executive officer of Genetics Squared, a three-year-old life sciences firm that uses computers rather than wet labs for discovery and analysis.

John Freshley, who most recently was director of corporate development and marketing for STATPROBE, a clinical research firm, will assume the new position in a full-time capacity June 15. He joins Bill Worzel, co-founder and chief technical officer, as the early-stage drug development firm broadens its management. Freshley's experience also includes senior management responsibility in software development as well as biotechnology companies. Freshley consulted with Genetics Squared for the past two years to develop its strategic plan.

Speech at BIO Mid-America Venture Forum

Freshley will introduce the firm May 5, 2004 in a speech at the BIO Mid-America Venture Forum in St. Louis.

Earlier, Freshley was an executive with grapevine Technologies, a knowledge management software firm, and Biotherapies, which worked to develop a protein for breast-cancer treatment.

With a strong background in business development, sales and marketing, Freshley broadens the expertise of the firm as it plans to significantly increase its revenues and customer base. He joins Bill Worzel who co-developed the patented technology that the firm uses in its product work.

Patented Technology

The company is focused on using its novel analysis software to rapidly advance clinical development of products by identifying characteristics of patients most likely to respond to new therapies, Freshley explained.

"We have an innovative and proven proprietary and patented technology that solves problems other methods cannot," Freshley explained. "The technology has been tested in pharmaceutical and academic projects and the proof-of-concept is complete," he noted. "We are excited by the opportunity to impact patient treatment by ensuring the right patients get treated with the right therapy at the right time."

Genetics Squared

CONTACT: Larry T. Eiler of Eiler Communications, +1-734-761-3399, or+1-734-646-6593, or larry@eilerpr.com, for Genetics Squared



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES